Aptose Biosciences Provides Update on Hanmi Pharmaceutical Deal Closing Timeline
Aptose updates the timeline for its deal with Hanmi, shedding light on regulatory implications and the trend of pharmaceutical collaboration…
Replimune's Stock Soars 40% Following FDA Agreement on Melanoma Drug Resubmission
Replimune's stock skyrocketed 40% after an FDA agreement on its melanoma drug resubmission, signaling potential shifts in the biotech landsc…
PharmaCorp Expands into Canadian Pharmacy Market with Acquisition of PharmaChoice Canada
PharmaCorp's acquisition of PharmaChoice Canada marks a pivotal expansion into the Canadian pharmacy sector, signaling growth potential.
Vireo Growth's Strategic Acquisition of Bridgewell Agribusiness: A Move to Strengthen Cannabis Operations
Vireo Growth Inc. is set to acquire Bridgewell Agribusiness, a strategic move aimed at enhancing its role in the cannabis market.
Humacyte's VA Contract: A Milestone for Symvess Surgical Implants
Humacyte secures a vital contract with the VA for Symvess, boosting access to 170 hospitals and highlighting its potential in vascular proce…
Eli Lilly's Strategic Acquisition of Engage Bio: A Game Changer in Gene Therapy
Eli Lilly's acquisition of Engage Bio for up to $202 million positions it as a key player in non-viral gene delivery.